Marcos E. Milla

Research interests

Publications

• An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism

  Nature Communications · 2021 · 10.1038/s41467-021-24987-9

• Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation

  Proceedings of the National Academy of Sciences · 2014 · 10.1073/pnas.1322807111

• AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

  British Journal of Pharmacology · 2010 · 10.1111/j.1476-5381.2010.00796.x

• Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury

  Proceedings of the National Academy of Sciences · 2007 · 10.1073/pnas.0606344104

• Inhibition of the Tumor Necrosis Factor-α-converting Enzyme by Its Pro Domain

  Journal of Biological Chemistry · 2004 · 10.1074/jbc.m401311200

• The Τumor Necrosis Factor-α Converting Enzyme (TACE): A Unique Metalloproteinase with Highly Defined Substrate Selectivity

  Biochemistry · 2002 · 10.1021/bi0260132

• Protein Kinase C-dependent α-Secretase Competes with β-Secretase for Cleavage of Amyloid-β Precursor Protein in the Trans-Golgi Network

  Journal of Biological Chemistry · 2000 · 10.1074/jbc.275.4.2568

• Specific Sequence Elements Are Required for the Expression of Functional Tumor Necrosis Factor-α-converting Enzyme (TACE)

  Journal of Biological Chemistry · 1999 · https://doi.org/10.1074/jbc.274.43.30563

• Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

  Nature · 1997 · https://doi.org/10.1038/385733a0

• p22 Arc Repressor: Folding Kinetics of a Single-Domain, Dimeric Protein

  Biochemistry · 1994 · 10.1021/bi00171a011

• Protein stability effects of a complete set of alanine substitutions in Arc repressor

  Nature Structural Biology · 1994 · 10.1038/nsb0894-518

Current projects

No projects listed.